Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
AddLife AB is a leading provider of medical technology and supplies in the Nordic region, focusing on laboratory and medical equipment, as well as consumables. The company's competitive position is bolstered by its extensive distribution network and strong relationships with healthcare providers across Sweden, Norway, Denmark, and Finland.
AddLife generates revenue primarily through the sale of medical and laboratory supplies, leveraging its established distribution channels and strong supplier relationships. The company benefits from pricing power due to its reputation for quality and reliability in the healthcare sector.
Changes in healthcare spending in the Nordic region
Regulatory changes affecting medical device approvals
Market share gains in laboratory equipment
Emerging healthcare trends, such as telemedicine and home diagnostics
Technological disruption in medical devices and diagnostics
Regulatory changes impacting product approvals and market access
Intensifying competition from global medical supply companies
Potential price wars in key product segments
Moderate financial risk due to existing debt levels
Liquidity risk if cash flow generation does not meet expectations
moderate - AddLife's performance is somewhat tied to GDP growth, as increased economic activity typically leads to higher healthcare spending.
Interest rates affect AddLife primarily through financing costs for inventory and equipment purchases. Higher rates could compress margins if costs rise without corresponding price increases.
minimal - The company has a manageable debt level (Debt/Equity of 0.85) and does not heavily rely on credit for operations.
growth - Investors are likely attracted to AddLife for its potential to capture market share in a growing healthcare sector.
moderate - The stock has shown significant price volatility, particularly with recent performance declines.
